Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (22)

2022

  1. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 191-199

  2. Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. T4-T14

  3. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750

  4. SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity

    Frontiers in Allergy, Vol. 3

  5. Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens

    Annals of Allergy, Asthma and Immunology, Vol. 128, Núm. 3, pp. 283-290.e4

2021

  1. Aradyal: The spanish multidisciplinary research network for allergic diseases

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 108-119

  2. Author Correction: MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia (Scientific Reports, (2018), 8, 1, (11628), 10.1038/s41598-018-29965-8)

    Scientific Reports

  3. Erratum: MYO1F Regulates IgE and MRGPRX2-Dependent Mast Cell Exocytosis (Journal of Immunology (2021) 206 (2277-2289) DOI: 10.4049/jimmunol.2001211)

    Journal of Immunology

  4. Hypersensitivity reactions to cancer chemotherapy: Practical recommendations of aradyal for diagnosis and desensitization

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 5, pp. 364-384

  5. MYO1F regulates IgE and MRGPRX2-dependent mast cell exocytosis

    Journal of Immunology, Vol. 206, Núm. 10, pp. 2277-2289

  6. Management of hypersensitivity reactions to chemotherapy and biologic agents: A survey of ARADyAL (Asthma, Adverse Drug Reactions and Allergy Network) Spanish allergy services

    Allergy: European Journal of Allergy and Clinical Immunology

2020

  1. Diagnostic capacity of commercial extracts vs prick-by-prick in the study of sensitization to peanut: Which technique should we use?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 5, pp. 373-375

  2. Identification and Characterization of IgE-Reactive Proteins and a New Allergen (Cic a 1.01) from Chickpea (Cicer arietinum)

    Molecular Nutrition and Food Research, Vol. 64, Núm. 19

2019

  1. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)

    Health and Quality of Life Outcomes, Vol. 17, Núm. 1

2018

  1. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe

    Rhinology, Vol. 55, Núm. 1, pp. 34-38

  2. Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements

    Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144

  3. Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870

  2. Comparable actions of omalizumab on mast cells and basophils

    Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 92-102